FREDUN PHARMACEUTICALS L Share Price

FREDUN PHARMACEUTICALS L Share Price

NSE: FREDUN
|
Pharmaceuticals
|
S Cap
₹ 1,409.70
-₹51.50 (-3.52%)
1D
Last updated 11 Sep, 2026, 15:29 IST

FREDUN PHARMACEUTICALS L Share Price Today

As of 13 Sep 2026, FREDUN PHARMACEUTICALS L share price is ₹1,409.70. The stock opened at ₹1,450.00, compared to its previous close of ₹1,461.20. During today's trading session, FREDUN PHARMACEUTICALS L share price moved in the range of ₹1,400.00 to ₹1,450.00, with an average price of ₹1,425.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,320.10 and a high of ₹1,590.00. On the performance front, FREDUN PHARMACEUTICALS L share price has declined by 1.88% over the last six months and is down 1.88% on a year-on-year basis.

₹1,400.00
3.52% down today
₹1,450.00
1D LOW
1D HIGH

FREDUN PHARMACEUTICALS L Returns Calculator

Circuit
L
H
₹1,271.00
₹1,553.40
52-week
L
H
₹1,320.10
₹1,590.00

About FREDUN PHARMACEUTICALS L

FREDUN PHARMACEUTICALS L Share Price
ISIN
INE194R01017
Sector Market Cap
₹ 2,337.74 Cr

Fredun Pharmaceuticals Ltd. is an India-based pharmaceuticals formulation manufacturing company. The Company is engaged in manufacturing dietary/herbal supplements, nutraceuticals, and other healthcare products, along with animal healthcare products. Its segment includes Fredun Generics, Pet Care, Nutraceuticals, Cosmeceuticals and Mobility. Its Generics Division, marketed under the Fredun Gx brand. The Pet Healthcare segment operates under the Freossi brand. The Nutraceutical Division under Fredun Nutrition brand. Its Cosmeceuticals Division, operating under the Bird N Beauty (BNB) and Beautyfred brands, is focused on skincare and personal care products. Its Mobility Division, operating under Chuu Balm, BraceOn, NebOn, and DigiOn, caters to the ortho rehabilitation aids and pain management market. It offers a range of products, including antihypertensive, antidiabetic, antiretroviral drugs (ARVs) and narcotics. It also provides comprehensive pet care technology platforms.

FREDUN PHARMACEUTICALS L Financial Highlights

  • Revenue: FREDUN PHARMACEUTICALS L reported revenue of ₹639.12 crore in FY26 vs ₹456.27 crore in FY25. It showed an increase of 40.07% on a yearly basis.
  • Operating Profit: FREDUN PHARMACEUTICALS L reported an operating profit of ₹47.00 crore in FY26 vs ₹27.49 crore in FY25. It showed an increase of 70.97% on a year-on-year basis.
  • Net Profit: FREDUN PHARMACEUTICALS L reported a net profit of ₹32.62 crore in FY26 vs ₹19.74 crore in FY25. It showed an increase of 65.25% on a yearly basis.

FREDUN PHARMACEUTICALS L Quarterly Result Highlights

  • FREDUN PHARMACEUTICALS L reported revenue of ₹228.25 crore in Jun 2026, compared with ₹213.06 crore in Mar 2026, representing an increase of 7.13% on a quarter-on-quarter (QoQ) basis.
  • FREDUN PHARMACEUTICALS L reported an operating profit of ₹20.55 crore in Jun 2026, compared with ₹11.25 crore in Mar 2026, representing an increase of 82.67% on a quarter-on-quarter (QoQ) basis.
  • FREDUN PHARMACEUTICALS L reported a profit of ₹13.13 crore in Jun 2026, compared with ₹10.78 crore in Mar 2026, reflecting an increase of 21.80% on a QoQ basis.
  • The earnings per share (EPS) of FREDUN PHARMACEUTICALS L stood at ₹66.81 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
44.57%
FII
1.06%
Other DII
2.94%
Retail and other
51.43%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Feb 20261.06%
Mar 20261.06%
Jun 20261.06%
Jul 20261.06%
Mkt Cap Cr
2,337.74
P/E
53.34
P/B
8.68
ROE
11.73%
D/E
0.80
ROCE
17.24%
Div. Yield
0.02%
EPS(TTM)
68.01
Turnover
1.16
EV/EBITDA
22.60
Net Margin
5.23%
Op. Margin
14.92%
ROA
6.82%
Quick Ratio
0.77
Curr. Ratio
3.82
Based on fundamentals, this stock's
Step 2 of 5
Performance
Poor
Fredun Pharma has underperformed the market
Step 1 of 5
Valuation
Overvalued
Fredun Pharma appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Fredun Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,41,958.0036.485.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,47,576.0084.6414.7715.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,233.0087.7722.5025.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,11,671.0024.324.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,273.0032.863.2011.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,06,460.0097.6420.0916.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories96,906.4030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma96,401.7025.982.549.25%0.1911.76%394.820.24%0.3841.58
Lupin95,842.9017.274.2723.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,050.4045.495.7711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

FREDUN PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Revenue₹635.47₹453.82
Other Income₹3.66₹2.45
Total Revenue₹639.12₹456.27
Total Expenses₹592.13₹428.78
Profit Before Tax₹47.00₹27.49
Tax₹14.38₹7.75
Profit After Tax₹32.62₹19.74
EPS - Basic₹66.81₹41.78
EPS - Diluted₹61.23₹42.53

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Profit before tax₹32.62₹20.03
Income before WC changes₹80.84₹55.09
Change in Assets-₹28.56-₹169.59
Change in Liabilities-₹39.37₹97.91
Change in WC-₹67.93-₹71.68
Cash flow from Operations₹11.90-₹16.60
Cash flow from Investing-₹73.59-₹6.35
Cash flow from Financing₹121.45₹26.65
Total Cash Flow₹59.76₹3.70
Cash (Start of the year)₹5.22₹1.52
Cash (End of the year)₹64.98₹5.22

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Non-Current Assets₹143.91₹60.21
Current Assets₹498.17₹427.20
Total Assets₹642.08₹487.41
Current Liabilities₹296.86₹328.10
Net Current Asset₹201.31₹99.11
Non-Current Liabilities₹67.11₹17.93
Equity Capital₹278.11₹141.38
Total Equity & Liabilities₹642.08₹487.41

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹635.47₹453.82₹348.16₹274.68
Other Income₹3.66₹2.45₹0.92₹1.82
Total Revenue₹639.12₹456.27₹349.07₹276.50
Total Expenses₹591.54₹428.00₹327.62₹258.99
Profit Before Tax₹47.58₹28.27₹21.45₹17.51
Tax₹14.38₹7.46₹5.83₹6.70
Profit After Tax₹33.21₹20.81₹15.62₹10.81
EPS - Basic₹68.01₹44.83₹33.81₹24.13
EPS - Diluted₹62.33₹44.37₹33.47₹22.93

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹33.21₹20.81₹15.62₹10.76
Income before WC changes₹81.10₹55.27₹38.22₹29.16
Change in Assets-₹25.15-₹174.13-₹54.39-₹62.33
Change in Liabilities-₹39.93₹96.41₹15.73₹18.76
Change in WC-₹65.08-₹77.72-₹38.66-₹43.57
Cash flow from Operations₹16.44-₹20.98-₹0.44-₹14.41
Cash flow from Investing-₹73.58-₹5.99-₹7.64-₹9.40
Cash flow from Financing₹121.82₹25.90₹5.99₹25.18
Total Cash Flow₹64.67-₹1.07-₹2.08₹1.36
Cash (Start of the year)₹0.28₹1.35₹3.44₹2.07
Cash (End of the year)₹64.95₹0.28₹1.35₹3.44

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹143.89₹64.40₹50.46₹41.07
Current Assets₹498.24₹422.25₹257.14₹216.21
Total Assets₹642.14₹486.65₹307.60₹257.28
Current Liabilities₹296.31₹327.32₹166.83₹139.66
Net Current Asset₹201.93₹94.93₹90.31₹76.55
Non-Current Liabilities₹67.11₹17.93₹19.30₹21.25
Equity Capital₹278.71₹141.40₹121.47₹96.38
Total Equity & Liabilities₹642.14₹486.65₹307.60₹257.28
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
3
Neutral
3
Bullish
0
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
22.98
Bearish
ATR (14)
71.8
Neutral
STOCH(9,6)
43.67
Neutral
ADX(9)
67.35
Bearish
ROC(12)
-5.49
Bearish
WillR(14)
-57.34
Neutral
Period
Simple value
Exponential vaue
5D
1414.98
1430.23
10D
1448.44
1437.77
20D
1453.64
0
50D
1453.64
0
100D
1453.64
0
Volume trend — traded volume by day
11 Sep0L
10 Sep0L
9 Sep0L
8 Sep0L
7 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
FREDUN PHARMACEUTICALS L Share Price
FREDUN PHARMACEUTICALS L
Pharmaceuticals
Add Stock
Add Another

FREDUN PHARMACEUTICALS L Share Price FAQs

FREDUN PHARMACEUTICALS L share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837